Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Transurethral Resection of Prostate × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Thyroid Nodule 5 Carcinoma, Hepatocellular 4 Thyroid Neoplasms 3 Thyroid Cancer, Papillary 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Prostatic Hyperplasia 2 Melanoma 2 Liver Neoplasms 2 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Dysplasia 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Urinary Bladder, Neurogenic 1 Urinary Bladder Neoplasms 1 Spinal Dysraphism 1 Spinal Cord Compression 1 Recurrence 1 Precancerous Conditions 1 Papillomavirus Infections 1 Papillary Thyroid Microcarcinoma 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Hypospadias 1

Interventions

Oxaliplatin 42 Gemcitabine 41 Fluorouracil 37 pembrolizumab 29 Capecitabine 29 Leucovorin 26 Docetaxel 25 Cisplatin 24 Paclitaxel 21 Carboplatin 18 Bevacizumab 17 Irinotecan 16 130-nm albumin-bound paclitaxel 16 Radiotherapy 15 Pemetrexed 15 Nivolumab 13 Albumin-Bound Paclitaxel 13 Cyclophosphamide 10 Ramucirumab 9 zolbetuximab 7 Trastuzumab 7 Radiosurgery 7 Drug Therapy 7 trastuzumab deruxtecan 6 cemiplimab 6 Taxes 6 Erlotinib Hydrochloride 6 Blood Specimen Collection 6 durvalumab 5 Sorafenib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07237399 2025-12-26

TA-P-OLIM

University Hospital, Ghent

Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡